Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1P78
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,818
Award facts
- Contract value 100% obligated
- $88,817.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $88,817.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. REPATHA, a branded PCSK9 inhibitor used to treat high cholesterol, represents the type of specialized pharmaceutical product routinely procured through this vehicle to support Defense Health Agency operations and other federal healthcare systems. The contract demonstrates AmerisourceBergen's continued capability to fulfill federal procurement requirements through open competition for critical cardiovascular medications and specialty therapeutics.
Quick answers
Who was awarded contract SPE2DR26F1P78?
SPE2DR26F1P78 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F1P78 worth?
The government has obligated $88,818 on SPE2DR26F1P78.
Is contract SPE2DR26F1P78 an order under another contract?
Yes. SPE2DR26F1P78 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1P78 competed?
The extent of competition for SPE2DR26F1P78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award